0001650840-18-000001.txt : 20180111
0001650840-18-000001.hdr.sgml : 20180111
20180110204236
ACCESSION NUMBER: 0001650840-18-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180111
DATE AS OF CHANGE: 20180110
EFFECTIVENESS DATE: 20180111
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dance Biopharm Holdings, Inc.
CENTRAL INDEX KEY: 0001650840
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-300966
FILM NUMBER: 18522564
BUSINESS ADDRESS:
STREET 1: 2 MINT PLAZA, SUITE 804
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415-369-9415
MAIL ADDRESS:
STREET 1: 2 MINT PLAZA, SUITE 804
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
FORMER COMPANY:
FORMER CONFORMED NAME: Dance BioPharm Holdings, Inc.
DATE OF NAME CHANGE: 20150812
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001650840
Dance Biopharm Holdings, Inc.
2 MINT PLAZA, SUITE 804
SAN FRANCISCO
CA
CALIFORNIA
94103
415-369-9415
DELAWARE
SAV Holdings Corp.
Dance BioPharm Holdings, Inc.
Corporation
true
2013
John
S.
Patton, Ph.D
2 Mint Plaza, Suite 804
San Francisco
CA
CALIFORNIA
94103
Executive Officer
Director
Donald
D.
Huffman
2 Mint Plaza, Suite 804
San Francisco
CA
CALIFORNIA
94103
Executive Officer
Director
Lisa
E.
Porter, M.D.
2 Mint Plaza, Suite 804
San Francisco
CA
CALIFORNIA
94103
Executive Officer
Vivian
Yan
2 Mint Plaza, Suite 804
San Francisco
CA
CALIFORNIA
94103
Director
Steven
Thornton
2 Mint Plaza, Suite 804
San Francisco
CA
CALIFORNIA
94103
Director
Adam
K.
Stern
c/o Aegis Capital Corp.
810 Seventh Ave., 18th Floor
New York
NY
NEW YORK
10019
Director
Biotechnology
Decline to Disclose
- 06b
true
0001650840-17-000005
2017-11-30
false
true
true
true
false
0
Aegis Capital Corp
15007
None
None
810 Seventh Avenue, 18th Floor
New York
NY
NEW YORK
10019
CA
CALIFORNIA
CO
COLORADO
CT
CONNECTICUT
FL
FLORIDA
GA
GEORGIA
IL
ILLINOIS
IN
INDIANA
IA
IOWA
KY
KENTUCKY
MD
MARYLAND
MA
MASSACHUSETTS
MN
MINNESOTA
MO
MISSOURI
NE
NEBRASKA
NV
NEVADA
NJ
NEW JERSEY
NM
NEW MEXICO
NY
NEW YORK
NC
NORTH CAROLINA
OH
OHIO
OR
OREGON
PA
PENNSYLVANIA
SC
SOUTH CAROLINA
TN
TENNESSEE
TX
TEXAS
VA
VIRGINIA
WA
WASHINGTON
false
36699455
19033459
17665996
false
135
1392433
true
0
Placement Agent is entitled to receive up to 10% cash and expense fees. Does not include value of warrants or royalty payment rights issuable to Placement Agent
0
true
Proceeds to be used as working capital, including payment of officer and employee salaries. A portion of the proceeds to be used to compensate Placement Agent. Adam Stern, a director of the issuer, is an affiliate of the Placement Agent.
false
Dance Biopharm Holdings, Inc.
/John S. Patton Ph.D/
John S. Patton Ph.D
Chief Executive Officer
2018-01-09